5Lundell L, Myers JC, Jamieson GG. Is motility impaired in the entire upper gastrointestinal tract in patients with gastro-oesophageal reflux disease? Scand J Gastroenterol 1996; 31: 131-135
6Rydberg L, Ruth M, Lundell L. Does oesophageal motor function improve with time after successful antireflux surgery? Results of a prospective, randomized clinical study. Gut 1997; 41: 82-86
7Achem SR, Robinson M. A prokinetic approach to treatment of gastroesophageal reflux disease. Dig Dis 1998; 16: 38-46
8Ramirez B, Richter JE. Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1993; 7: 5-20
9Kim YB, Song CW, Kim HR, Lee SW, Bak YT, Hyun JH, Moon JS, Park HC. The incidence of gastroesophageal reflux disease and the effect of cisapride in patients with epigastric soreness. Korean J Gastrointestinal Motility 2000; 6: 168-195
10Richter JE, Long JF. Cisapride for gastroesophageal reflux disease: a placebo-controlled, double-blind study. Am J Gastroenterol 1995; 90: 423-430
